BTIG Downgrades DermTech Inc. (DMTK) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Lake Street Capital Markets Downgrades DermTech Inc. (DMTK) to Hold
April 19, 2024 7:29 AM EDTLake Street Capital Markets analyst Thomas Flaten downgraded DermTech Inc. (NASDAQ: DMTK) from Buy to Hold with a price target of $0.63.
For an analyst ratings summary and ratings history on DermTech Inc. click here. For more ratings news on DermTech Inc. click here.
Shares of DermTech Inc. closed at $0.59 yesterday.
... MoreDermTech (DMTK) to Explore Strategic Alternatives and Implement Restructuring Plan
April 18, 2024 4:16 PM EDTDermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the special committee of its board of directors engaged TD Cowen to conduct a process exploring strategic alternatives to maximize stockholder value. Potential strategic alternatives that may be explored or evaluated include an acquisition, merger,... More
